AHCYL1 and adenocarcinoma: Particularly, AHCYL1 shows a significantly lower expression in recurrences and metastases compared to primary biopsies (Fig. 1C) in LUAD samples, suggesting that adenocarcinoma with higher metastatic potential show lower AHCYL1 expression.